Clinical and microbiological analysis of risk factors for breakthrough bloodstream infection during Tigecycline Therapy
In cases where there is a high suspicion of breakthrough BSI during tigecycline therapy, meticulous management and prudent selection of empirical antibiotics are crucial due to the diverse range of causative microorganisms involved.
Authors
- Eun Hee Song (ORCID: https://orcid.org/0000-0001-9939-3227)
- Yong Chong (ORCID: https://orcid.org/0000-0002-8804-3181)
- Sang‐Oh Lee (ORCID: https://orcid.org/0000-0003-1381-8787)
- So Yun Lim (ORCID: https://orcid.org/0000-0002-5647-3718)
- Heungsup Sung
- Jiwon Jung (ORCID: https://orcid.org/0000-0003-4333-3270)
- Yun Woo Lee (ORCID: https://orcid.org/0000-0001-6452-4020)
- Seongman Bae (ORCID: https://orcid.org/0000-0001-6375-3657)
- Sol Jin (ORCID: https://orcid.org/0000-0002-8720-2005)
- Sang‐Ho Choi (ORCID: https://orcid.org/0000-0002-4972-4531)
- Mi‐Na Kim (ORCID: https://orcid.org/0000-0002-4624-6925)
- Sung‐Han Kim (ORCID: https://orcid.org/0000-0002-6596-8253)
- Min Jae Kim (ORCID: https://orcid.org/0000-0002-5489-8608)
- Yang Soo Kim
Institutions
- Ulsan College (KR)
- Kosin University Gospel Hospital (KR)
- Asan Medical Center (KR)
- University of Ulsan (KR)
- Gangneung Asan Hospital (KR)
Publication Details
- Journal
- Scientific Reports
- Published
- 2025-02-04
- DOI
- https://doi.org/10.1038/s41598-025-88048-7
- Citations
- 2
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 1.18
Funders
- National Research Foundation of Korea
- Asan Institute for Life Sciences, Asan Medical Center